Quarry LP Buys Shares of 6,117 Inogen, Inc. (NASDAQ:INGN)

Quarry LP purchased a new position in shares of Inogen, Inc. (NASDAQ:INGNFree Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 6,117 shares of the medical technology company’s stock, valued at approximately $59,000.

Several other hedge funds have also made changes to their positions in the business. Price T Rowe Associates Inc. MD grew its holdings in shares of Inogen by 5.2% in the first quarter. Price T Rowe Associates Inc. MD now owns 23,868 shares of the medical technology company’s stock valued at $193,000 after purchasing an additional 1,188 shares in the last quarter. Meeder Asset Management Inc. purchased a new position in Inogen in the 2nd quarter valued at approximately $30,000. BNP Paribas Financial Markets grew its stake in shares of Inogen by 13.9% in the third quarter. BNP Paribas Financial Markets now owns 42,137 shares of the medical technology company’s stock worth $409,000 after acquiring an additional 5,131 shares in the last quarter. CWM LLC increased its position in shares of Inogen by 2,185.9% during the second quarter. CWM LLC now owns 6,629 shares of the medical technology company’s stock worth $54,000 after acquiring an additional 6,339 shares during the period. Finally, Meros Investment Management LP increased its position in shares of Inogen by 1.6% during the second quarter. Meros Investment Management LP now owns 397,209 shares of the medical technology company’s stock worth $3,229,000 after acquiring an additional 6,385 shares during the period. Institutional investors and hedge funds own 89.94% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on INGN shares. StockNews.com cut Inogen from a “buy” rating to a “hold” rating in a research note on Thursday, November 21st. Needham & Company LLC reiterated a “hold” rating on shares of Inogen in a research note on Friday, November 8th.

View Our Latest Research Report on INGN

Inogen Trading Up 0.1 %

Shares of INGN opened at $9.51 on Tuesday. The firm has a market capitalization of $226.53 million, a price-to-earnings ratio of -4.23 and a beta of 1.02. The firm’s fifty day simple moving average is $9.50 and its 200-day simple moving average is $9.70. Inogen, Inc. has a twelve month low of $5.08 and a twelve month high of $13.33.

Inogen Company Profile

(Free Report)

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Read More

Want to see what other hedge funds are holding INGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inogen, Inc. (NASDAQ:INGNFree Report).

Institutional Ownership by Quarter for Inogen (NASDAQ:INGN)

Receive News & Ratings for Inogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen and related companies with MarketBeat.com's FREE daily email newsletter.